Amicus Therapeutics Announces Second Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amicus Therapeutics Announces Second Quarter 2022 Financial Results

Amicus Therapeutics (FOLD) Reports In-Line Q2 EPS

August 4, 2022 7:33 AM EDT

Amicus Therapeutics (NASDAQ: FOLD) reported Q2 EPS of ($0.21), in-line with the analyst estimate of ($0.21). Revenue for the quarter came in at $80.7 million versus the consensus estimate of $85.87 million.

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

... More